{"id":"https://openalex.org/W2015102995","doi":"https://doi.org/10.1002/jps.24164","title":"Safety and Biosimilarity of ior\u00aeEPOCIM Compared with Eprex\u00ae Based on Toxicologic, Pharmacodynamic, and Pharmacokinetic Studies in the Sprague\u2013Dawley Rat","display_name":"Safety and Biosimilarity of ior\u00aeEPOCIM Compared with Eprex\u00ae Based on Toxicologic, Pharmacodynamic, and Pharmacokinetic Studies in the Sprague\u2013Dawley Rat","publication_year":2014,"publication_date":"2014-09-22","ids":{"openalex":"https://openalex.org/W2015102995","doi":"https://doi.org/10.1002/jps.24164","mag":"2015102995","pmid":"https://pubmed.ncbi.nlm.nih.gov/25250536"},"language":"en","primary_location":{"id":"doi:10.1002/jps.24164","doi":"https://doi.org/10.1002/jps.24164","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.24164","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069401437","display_name":"Kresimir Pucaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135382","display_name":"Nucro Technics","ror":"https://ror.org/03yxrd274","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210135382"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kresimir Pucaj","raw_affiliation_strings":["Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4","institution_ids":["https://openalex.org/I4210135382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084643927","display_name":"Katherine Riddle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135382","display_name":"Nucro Technics","ror":"https://ror.org/03yxrd274","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210135382"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Katherine Riddle","raw_affiliation_strings":["Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4","institution_ids":["https://openalex.org/I4210135382"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simon R. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135382","display_name":"Nucro Technics","ror":"https://ror.org/03yxrd274","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210135382"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Simon R. Taylor","raw_affiliation_strings":["Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4","institution_ids":["https://openalex.org/I4210135382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007148831","display_name":"Nuris Led\u00f3n","orcid":"https://orcid.org/0000-0003-3284-0541","observed_orcids":["https://orcid.org/0000-0003-3284-0541"]},"institutions":[{"id":"https://openalex.org/I2355400","display_name":"Center of Molecular Immunology (Cuba)","ror":"https://ror.org/01gh7yb82","country_code":"CU","type":"company","lineage":["https://openalex.org/I2355400"]}],"countries":["CU"],"is_corresponding":true,"raw_author_name":"Nuris Ledon","raw_affiliation_strings":["Centre of Molecular Immunology, CIMAB S.A., Atabey, Playa, Cuba. Electronic address: Nuris@cim.sld.cu","Centre of Molecular Immunology, CIMAB S.A., Atabey, Playa, Cuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Molecular Immunology, CIMAB S.A., Atabey, Playa, Cuba. Electronic address: Nuris@cim.sld.cu","institution_ids":[]},{"raw_affiliation_string":"Centre of Molecular Immunology, CIMAB S.A., Atabey, Playa, Cuba","institution_ids":["https://openalex.org/I2355400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030002656","display_name":"Gordon T. Bolger","orcid":"https://orcid.org/0000-0003-0971-5064","observed_orcids":["https://orcid.org/0000-0003-0971-5064"]},"institutions":[{"id":"https://openalex.org/I4210135382","display_name":"Nucro Technics","ror":"https://ror.org/03yxrd274","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210135382"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Gordon T. Bolger","raw_affiliation_strings":["Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nucro-Technics, Toronto, Ontario, Canada, M1H 2W4","institution_ids":["https://openalex.org/I4210135382"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007148831"],"corresponding_institution_ids":["https://openalex.org/I2355400"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.1373,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.47968062,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"103","issue":"11","first_page":"3432","last_page":"3441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eprex","display_name":"Eprex","score":0.9679999947547913},{"id":"https://openalex.org/keywords/recombinant-human-erythropoietin","display_name":"recombinant human erythropoietin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/biosimilarity","display_name":"biosimilarity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6430000066757202},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7409999966621399},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/thrombotic-adverse-events","display_name":"thrombotic adverse events","score":0.6809999942779541},{"id":"https://openalex.org/keywords/antidrug-antibodies","display_name":"antidrug antibodies","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7009999752044678},{"id":"https://openalex.org/keywords/sprague-dawley-rats","display_name":"Sprague-Dawley rats","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.837156355381012},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.735869288444519},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.654039204120636},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5146552324295044},{"id":"https://openalex.org/C195289149","wikidata":"https://www.wikidata.org/wiki/Q2256694","display_name":"Toxicokinetics","level":3,"score":0.4962947964668274},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28865936398506165}],"mesh":[{"descriptor_ui":"D000068817","descriptor_name":"Epoetin Alfa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066007","descriptor_name":"Toxicokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jps.24164","doi":"https://doi.org/10.1002/jps.24164","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.24164","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:25250536","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25250536","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Comparative Study"},{"id":"pmid:28238900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28238900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W79386389","https://openalex.org/W1129691885","https://openalex.org/W1990570851","https://openalex.org/W2005848612","https://openalex.org/W2098758993","https://openalex.org/W2105759045","https://openalex.org/W2111027588","https://openalex.org/W2122038099","https://openalex.org/W2135137305","https://openalex.org/W2136733759","https://openalex.org/W2141733091","https://openalex.org/W2163894227","https://openalex.org/W2166126901","https://openalex.org/W2264645549"],"related_works":["https://openalex.org/W2519678902","https://openalex.org/W4408006463","https://openalex.org/W4391945449","https://openalex.org/W1677866495","https://openalex.org/W4318698458","https://openalex.org/W2201338587","https://openalex.org/W4399444578","https://openalex.org/W2069809251","https://openalex.org/W2087004688","https://openalex.org/W2117653606"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}